- Home
- ATRA vs FBIO Comparison
ATRA vs FBIO Comparison
Compare ATRA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- FBIO
- Stock Information
- Founded
- ATRA 2012
- FBIO 2006
- Country
- ATRA United States
- FBIO United States
- Employees
- ATRA N/A
- FBIO N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- FBIO Health Care
- Exchange
- ATRA Nasdaq
- FBIO Nasdaq
- Market Cap
- ATRA 67.9M
- FBIO 88.7M
- IPO Year
- ATRA 2014
- FBIO N/A
- Fundamental
- Price
- ATRA $12.07
- FBIO $3.56
- Analyst Decision
- ATRA Strong Buy
- FBIO Strong Buy
- Analyst Count
- ATRA 3
- FBIO 2
- Target Price
- ATRA $21.00
- FBIO $16.50
- AVG Volume (30 Days)
- ATRA 44.8K
- FBIO 1.3M
- Earning Date
- ATRA 11-11-2025
- FBIO 11-13-2025
- Dividend Yield
- ATRA N/A
- FBIO N/A
- EPS Growth
- ATRA N/A
- FBIO N/A
- EPS
- ATRA 0.56
- FBIO N/A
- Revenue
- ATRA $188,667,000.00
- FBIO $59,301,000.00
- Revenue This Year
- ATRA N/A
- FBIO $49.84
- Revenue Next Year
- ATRA N/A
- FBIO $42.47
- P/E Ratio
- ATRA $21.29
- FBIO N/A
- Revenue Growth
- ATRA 202.41
- FBIO N/A
- 52 Week Low
- ATRA $5.01
- FBIO $1.33
- 52 Week High
- ATRA $18.71
- FBIO $3.97
- Technical
- Relative Strength Index (RSI)
- ATRA 52.51
- FBIO 66.40
- Support Level
- ATRA $11.70
- FBIO $3.36
- Resistance Level
- ATRA $12.50
- FBIO $3.97
- Average True Range (ATR)
- ATRA 0.58
- FBIO 0.31
- MACD
- ATRA -0.12
- FBIO 0.00
- Stochastic Oscillator
- ATRA 39.46
- FBIO 73.55
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.